Ultragenyx Pharmaceutical, Inc. (RARE)
26.14
+0.21
(+0.81%)
USD |
NASDAQ |
May 07, 16:00
26.14
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical SG&A Expense (TTM) : 262.27M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| BioMarin Pharmaceutical, Inc. | 946.91M |
| Regeneron Pharmaceuticals, Inc. | 2.715B |
| Xencor, Inc. | 63.64M |
| REGENXBIO, Inc. | 82.86M |